About GC Aesthetics
GC Aesthetics is a company based in Dublin (Ireland) founded in 2007. It operates as a Direct-to-Consumer (D2C) and Professional Services. GC Aesthetics has raised $232.81 million across 8 funding rounds from investors including Hayfin, Orbimed and Montreux Equity Partners. GC Aesthetics offers products and services including GCA Breast Implants, Nagor Implants, and GCA Comfort Plus Warranty. GC Aesthetics operates in a competitive market with competitors including Sientra, Establishment Labs, AirXpanders, BioAesthetics and Novasys Medical, among others.
- Headquarter Dublin, Ireland
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gc Aesthetics®
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$232.81 M (USD)
in 8 rounds
-
Latest Funding Round
$97 M (USD), Series E
Oct 29, 2018
-
Investors
Hayfin
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GC Aesthetics
GC Aesthetics offers a comprehensive portfolio of products and services, including GCA Breast Implants, Nagor Implants, and GCA Comfort Plus Warranty.
Breast implants are provided for aesthetic enhancement purposes.
Nagor implants are offered for natural breast augmentation.
Warranty services are extended for breast implant patients.
People of GC Aesthetics
Unlock access to complete
Funding Insights of GC Aesthetics
GC Aesthetics has successfully raised a total of $232.81M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $97 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series E — $97.0M
-
First Round
First Round
(06 Jul 2009)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Debt – Conventional - GC Aesthetics | Valuation |
investors |
|
| Oct, 2018 | Amount | Series E - GC Aesthetics | Valuation | Montreux Equity Partners , Barry’s Tea |
|
| Aug, 2018 | Amount | Series D - GC Aesthetics | Valuation | Montreux Equity Partners |
Investors in GC Aesthetics
GC Aesthetics has secured backing from 17 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Hayfin, Orbimed and Montreux Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt investments are directed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Growth capital investments are made in healthcare and fintech companies.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GC Aesthetics
Financial Statements - GC Aesthetics
Gc Aesthetics Comparisons
Competitors of GC Aesthetics
GC Aesthetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sientra, Establishment Labs, AirXpanders, BioAesthetics and Novasys Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Products for plastic surgery and aesthetics are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Silicone-filled breast and body shaping implants are designed and manufactured.
|
|
| domain | founded_year | HQ Location |
Tissue expansion technology for breast reconstruction surgery is developed.
|
|
| domain | founded_year | HQ Location |
Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use.
|
|
| domain | founded_year | HQ Location |
Therapeutics for female pelvic disorders, including SUI treatments, were developed.
|
Frequently Asked Questions about GC Aesthetics
GC Aesthetics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
GC Aesthetics is headquartered in Dublin, Ireland.
Carlos Reis Pinto is the current CEO of GC Aesthetics.
GC Aesthetics is a funded company, having raised a total of $232.81M across 8 funding rounds to date. The company's 1st funding round was a Series D of $7.51M, raised on Jul 06, 2009.
GC Aesthetics is involved in the development and distribution of breast implants for aesthetic and reconstructive surgeries. The company operates within the healthcare sector, focusing on medical devices. Solutions such as GCA Breast Implants and Nagor Implants are offered to enhance patient confidence and body image. Additionally, comprehensive warranty programs like GCA Comfort Plus are provided to ensure patient satisfaction and safety.
GC Aesthetics's top competitors include Establishment Labs, Sientra and BioAesthetics.
GC Aesthetics offers GCA Breast Implants, Nagor Implants, and GCA Comfort Plus Warranty.
GC Aesthetics has 17 investors. Key investors include Hayfin, Orbimed, Montreux Equity Partners, Barry's Tea, and bill mccabe.
The valuation of GC Aesthetics is $111.4M as of Aug 2017.